Foire aux questions concernant les candidats-vaccins contre la COVID-19 et les mécanismes d’accès, 27 août 2020
Abstract
Existe-t-il un vaccin contre la COVID-19? Tous les candidats-vaccins atteindront-ils le marché? Quelles sont les différentes phases avant qu’un vaccin soit homologué? Ce document répond aux questions les plus fréquentes sur les candidats-vaccins et les mécanismes d’accès dont disposent les pays pour accéder aux vaccins.
Subject
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
CESS1/3: Emergency Loan from the Revolving Fund for Access to Vaccines to the Regional Revolving Fund for Strategic Public Health Supplies
(Washington, D.C., PAHO, 2020-05-29) -
CESS1.R1: Emergency Loan from the Revolving Fund for Access to Vaccines to the Regional Revolving Fund for Strategic Public Health Supplies
(Washington, D.C., PAHO, 2020-05-29) -
Summary on Advances in the Development of Vaccines against COVID-19, 3 April 2020
(Washington, D.C., PAHO, 2020-06-03)This document presents a brief summary of vaccines in development for COVID-19. At the end of 2019, the new SARS-CoV-2 coronavirus emerged. Although there is not yet a vaccine against this virus, the field of research for ...
